XML 25 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Operating Activities    
Net Income (Loss) $ (981,395) $ 11,459,886
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities:    
Equity-Based and Other Non-Cash Compensation 559,621 296,323
Change in Unrealized (Gains) Losses - Asset Management 2,508,970 (6,499,944)
Net Accretion and Amortization 330,781 324,692
Other Non-Cash Amounts 37,268 101,904
Cash Flows Due to Changes in Operating Assets and Liabilities:    
Change in Consolidation (66,593) (24,183)
Change in Due from / to Affiliates (163,667) (243,120)
Change in Other Assets 1,462,938 669,361
Change in Accrued Expenses and Other Liabilities (2,783,578) 2,608,487
Net Cash Provided (Used) by Operating Activities (4,631,724) (3,558,499)
Investing Activities    
Purchases of Fixed Assets (58,584) (82,515)
Net Cash Provided (Used) by Investing Activities (10,681,162) (7,017,238)
Financing Activities    
Common Stock Dividends (310,869) (246,653)
Distributions to Redeemable Noncontrolling Interests (1,905) (1,362)
Distributions to Noncontrolling Interests (5,759,604) (3,975,764)
Contributions from Noncontrolling Interests 11,033,195 8,875,106
Redemption of Series A and B Preferred Stock 0 (500,000)
Net Delivery of Common Stock (Equity Incentive Plans) (34,874) (106,914)
Repurchases of Common Stock (346,651) (135,930)
Private Placement Share Issuance 0 38,463
Proceeds from Debt Obligations 17,191,850 20,615,117
Repayment of Debt Obligations (12,328,191) (13,881,246)
Financing Costs Paid (32,559) (93,914)
Net Cash Provided (Used) by Financing Activities 16,651,027 16,126,114
Effect of exchange rate changes on cash, cash equivalents and restricted cash (234,580) (31,022)
Net Increase/(Decrease) in Cash, Cash Equivalents and Restricted Cash 1,103,561 5,519,355
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 10,526,304 6,993,457
Cash, Cash Equivalents and Restricted Cash, End of Period 11,629,865 12,512,812
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 11,629,865 12,512,812
Supplemental Disclosures of Cash Flow Information    
Payments for Interest 1,112,596 876,412
Payments for Income Taxes 556,195 463,983
Payments for Operating Lease Liabilities 37,533 35,124
Supplemental Disclosures of Non-Cash Investing and Financing Activities    
Equity-Based and Other Non-Cash Contributions 459,327 235,381
Non-Cash Contribution from Noncontrolling Interests 84,786 845,943
Debt Obligations - Net Gains (Losses), Translation and Other 3,056,342 272,410
Holdings Merger (See Note 1) 6,959,322 0
Tax Effects - Exchange of KKR Holdings L.P. Units and Other (See Note 1) (1,064,790) (1,623)
Right-of-Use Assets obtained in Exchange for new Operating Lease Liabilities 47,032 44,754
Investments Acquired through Reinsurance Agreements 2,697,956 16,133,534
Policyholder Liabilities and Accruals Acquired through Reinsurance Agreements 965,829 3,455,904
Contractholder Deposit Funds Acquired through Reinsurance Agreements 2,544,504 14,809,751
Change in Consolidation    
Investments (57,440) (64,957)
Due From Affiliates 0 (3,735)
Other Assets (59,675) (46,352)
Debt Obligations (50,339) (26,165)
Due to Affiliates (174) (238)
Accrued Expenses and Other Liabilities (4,162) (11,626)
Noncontrolling Interests 0 (78,840)
Global Atlantic    
Investing Activities    
Acquisitions, net of cash acquired 0 (473,779)
KJR Management    
Investing Activities    
Acquisitions, net of cash acquired (1,690,702) 0
Asset Management    
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities:    
Net Realized (Gains) Losses - Asset Management (1,158,582) (1,532,956)
Change in Unrealized (Gains) Losses - Asset Management 2,508,970 (6,499,944)
Capital Allocation-Based (Income) Loss - Asset Management 2,442,080 (5,736,707)
Cash Flows Due to Changes in Operating Assets and Liabilities:    
Investments Purchased - Asset Management (32,517,281) (55,435,501)
Proceeds from Investments - Asset Management 23,595,202 48,286,348
Financing Activities    
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 6,833,966 6,993,457
Cash, Cash Equivalents and Restricted Cash, End of Period 7,112,885 7,397,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and Cash Equivalents 6,911,691 7,256,382
Restricted Cash and Cash Equivalents 201,194 140,618
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 7,112,885 7,397,000
Insurance    
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided (Used) by Operating Activities:    
Net Realized (Gains) Losses - Insurance 235,888 642,557
Interest Credited to Policyholder Account Balances (net of Policy Fees) - Insurance 1,009,636 938,415
Cash Flows Due to Changes in Operating Assets and Liabilities:    
Reinsurance Transactions and Acquisitions, Net of Cash Provided - Insurance 715,716 1,041,130
Change in Premiums, Notes Receivable and Reinsurance Recoverable, Net of Reinsurance Premiums Payable - Insurance 795,488 435,715
Change in Deferred Policy Acquisition Costs - Insurance (368,144) (307,031)
Change in Policy Liabilities and Accruals, Net - Insurance (286,072) (583,875)
Investing Activities    
Investments Purchased - Insurance (37,207,043) (38,215,238)
Proceeds from Investments - Insurance 28,301,478 32,463,286
Other Investing Activities, Net - Insurance (26,311) (708,992)
Financing Activities    
Additions to Contractholder Deposit Funds - Insurance 16,629,841 11,331,510
Withdrawals from Contractholder Deposit Funds - Insurance (9,863,212) (6,264,316)
Reinsurance Transactions, Net of Cash Provided - Insurance 54,749 524,724
Other Financing Activity, Net - Insurance 471,007 18,244
Cash, Cash Equivalents and Restricted Cash, Beginning of Period 3,692,338 0
Cash, Cash Equivalents and Restricted Cash, End of Period 4,516,980 5,115,812
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and Cash Equivalents 4,147,146 4,717,240
Restricted Cash and Cash Equivalents 369,834 398,572
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total 4,516,980 5,115,812
Series A And Series B Preferred Stock    
Financing Activities    
Preferred Stock Dividends 0 (19,201)
Series C Mandatory Convertible Preferred Stock Dividends    
Financing Activities    
Preferred Stock Dividends $ (51,750) $ (51,750)